Well Characterized Gene Therapies: Comparison of Analytical Strategies for Viral & Non-Viral Vectors

Time: 10:15 am
day: Focus Day


  • Determining the similarities and distinctions in critical quality attributes (CQAs) for viral and non-viral gene therapies
  • Outlining how drugs with different delivery methods and production processes can alter the analytical strategy
  • This presentation will focus on AAV- and C3-DNA-based gene therapies as examples